VH1410: Section on Advances in Therapeutics and Technology Program

Role of Research Enterprise in the Age of COVID-19

Monday, October 11, 2021

9:00 AM – 11:00 AM CDT

CME: 0.00

Session Type: Section/Council Program

Topic(s): Advances in Therapeutics and Technology

Sponsor(s): Section on Advances in Therapeutics and Technology

View full agenda here

The SARS-CoV-2 pandemic heightened urgency in translating evolving science into innovative research and development. With limited knowledge facilitating the scientific endeavor, public and private enterprise are at the forefront racing to understand and prevent SARS-CoV-2 illness in children. This session showcases two examples reimagining how we address gaps in pediatric knowledge.

Not designated for CME credit

Presenter(s)

Diana W. Bianchi, MD

Director
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Christina M. Bucci-Rechtweg, MD

Global Head, Pediatric & Maternal Health Policy
Novartis Pharmaceuticals
Laurel Hollow, New York, United States
Iona Munjal, MD

Director Vaccine Clinical Research and Development
Pfizer Vaccines
Ardsley, New York, United States
CR

Christopher Rizzo, MD FAAP

Section Chair
Cleveland, Ohio, United States

Award Recipient(s)

GM

Gerard Martin, MD, FAAP, FACC, FAHA